Skip to main content
. 2023 Nov 8;9(11):e21616. doi: 10.1016/j.heliyon.2023.e21616

Table 1.

Clinical characteristics of pregnant women with ICP and healthy pregnant controls.

Variable Screening Samples
Validation Samples
Control(n = 8) ICP(n = 8) P value Control(n = 20) ICP(n = 20) P value
Maternal age(years) 32.4 ± 4.9 31.4 ± 5.0 1.000 32.5 ± 5.6 31.6 ± 4.7 0.570
Delivery weeks 39.1 ± 0.4 37.0 ± 1.1 0.024* 39.3 ± 0.7 37.0 ± 1.6 0.004*
TBA(μmol/L) 2.7 ± 0.8 65.2 ± 48.2 0.005* 4.0 ± 2.0 53.0 ± 39.1 0.000*
ALT(IU/L) 9.1 ± 1.6 102.0 ± 69.5 0.000* 11.1 ± 7.0 102.0 ± 85.5 0.000*
AST(IU/L) 16.4 ± 3.4 67.8 ± 39.4 0.004* 18.2 ± 4.6 73.3 ± 61.7 0.000*
ALP(IU/L) 153.7 ± 65.2 236.1 ± 36.2 0.334 155.9 ± 57.4 216.8 ± 56.0 0.889
TBIL(μmol/L) 8.3 ± 3.1 14.8 ± 12.2 0.156 9.1 ± 3.1 12.3 ± 8.3 0.142
DBIL(μmol/L) 2.2 ± 1.0 7.8 ± 9.8 0.063 2.3 ± 0.9 5.6 ± 6.4 0.058
Newborn weight(g) 3391.3 ± 563.6 2914.4 ± 453.5 0.451 3579.5 ± 484.1 2975.0 ± 461.3 0.983